![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
16
Bearish Moving Averages
0
What’s Trending
Products
Investments
Back Stocks profile
Today’s low
4563.80Today’s High
4810.0052W low
3295.3052W High
4810.00Open Price
4571.00Prev. Close
4448.9000Volume
1311648.00Value
6283580908.80Market Cap
127175.40
Price to Earnings
79.50
Price to Book Value
9.40
Dividend Yield
0.60
PE to Growth
-6.50
Op Revenue TTM
7845.00
Net Profit TTM
1600.00
Cash From Operating Activity
1261.00
Return on Equity %
11.78
EMA & SMA
Bullish Moving Averages
16
Bearish Moving Averages
0
DELIVERY AND VOLUME
26 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
4879.12
Second Resistance
4967.63
Third Resistance
5125.27
First Support
4632.97
Second Support
4475.33
Third Support
4386.82
Relative Strength Index
68.31
Money Flow Index
50.39
MACD
46.82
MACD Signal
46.08
Average True Range
113.97
Average Directional Index
17.67
Rate of Change (21)
5.4
Rate of Change (125)
32.51
Commodity Channel Index
289.4
Williams %R
-4.7
BETA
1 Month
1.33
3 Month
0.37
1 Year
0.5
3 Year
0.14
PRICE CHANGE ANALYSIS
1 Week
Low
High
4395.3
4810
1 Month
Low
High
4395.3
4810
3 Months
Low
High
3724
4810
6 Months
Low
High
3350
4810
1 Year
Low
High
3295.3
4810
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 2338.00 | 1902.00 | 1953.00 | 1810.00 | 1974.32 | 1806.17 | 1902.63 | 2293.91 | 2545.54 | 2483.39 | 1986.97 | 1985.71 | 1741.24 | |
Operating Expenses Qtr | 1542.00 | 1317.00 | 1394.00 | 1239.00 | 1419.47 | 1280.41 | 1214.12 | 1366.34 | 1399.06 | 1366.87 | 1149.27 | 1098.69 | 1019.04 | |
Operating Profit Qtr | 717.00 | 491.00 | 474.00 | 491.00 | 488.70 | 409.42 | 609.26 | 837.58 | 1095.97 | 1099.90 | 818.59 | 851.47 | 699.35 | |
EBIDT Qtr Cr | 796.00 | 585.00 | 559.00 | 571.00 | 554.85 | 525.76 | 688.51 | 927.57 | 1146.48 | 1116.52 | 837.70 | 887.02 | 722.20 | |
Depreciation Qtr | 94.00 | 95.00 | 94.00 | 93.00 | 86.63 | 86.54 | 85.48 | 83.42 | 80.75 | 79.70 | 77.09 | 73.01 | 69.84 | |
Net Profit Qtr | 531.00 | 358.00 | 342.00 | 345.00 | 318.79 | 310.90 | 486.85 | 691.61 | 882.96 | 907.22 | 606.39 | 551.97 | 487.93 | |
Basic EPS Qtr | 19.99 | 13.50 | 12.89 | 12.99 | 12.01 | 11.71 | 18.34 | 26.05 | 33.26 | 34.17 | 22.84 | 20.79 | 18.38 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 8002.00 | 7974.31 | 8991.08 | 6861.14 | 5500.43 | |
Operating Expenses Annual Cr | 5491.00 | 5277.62 | 5003.36 | 3977.93 | 3495.13 | |
Operating Profit Annual | 2174.00 | 2347.68 | 3876.46 | 2820.68 | 1815.44 | |
Operating Profit Margin Annual % | 27.17 | 29.44 | 43.11 | 41.11 | 33.01 | |
Total Expenses Annual Cr | 5870.00 | 5620.21 | 5314.56 | 4233.27 | 3687.14 | |
EBIDT Annual Cr | 2511.00 | 2696.69 | 3987.72 | 2883.21 | 2005.30 | |
EBIDT Annual margin % | 31.38 | 33.82 | 44.35 | 42.02 | 36.46 | |
Depreciation | 376.00 | 342.07 | 310.55 | 254.65 | 185.95 | |
PAT Before ExtraOrdinary Items Annual Cr | 1576.00 | 1808.15 | 2948.54 | 1954.72 | 1372.71 | |
Net Profit Annual | 1576.00 | 1808.15 | 2948.54 | 1954.72 | 1372.71 | |
Basic EPS Annual | 59.37 | 68.11 | 111.07 | 73.63 | 51.71 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 13484.00 | 12705.42 | 11691.35 | 9271.57 | 7316.69 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 619.00 | 567.83 | 448.11 | 363.31 | 294.48 | |
Total Current Liabilities Annual Cr | 1259.00 | 1078.37 | 1168.40 | 1088.89 | 902.94 | |
Total Capital Plus Liabilities Annual Cr | 15362.00 | 14351.62 | 13307.86 | 10723.77 | 8514.11 | |
Fixed Assets Annual | 5515.00 | 4930.64 | 4790.90 | 4409.63 | 3695.95 | |
Total Non Current Assets Annual | 5790.00 | 5116.17 | 5011.90 | 4598.46 | 3852.94 | |
Total Current Assets Annual | 9572.00 | 9235.45 | 8295.96 | 6125.31 | 4661.17 | |
Total Assets Annual | 15362.00 | 14351.62 | 13307.86 | 10723.77 | 8514.11 | |
Contingent Liabilities plus Commitments Annual Cr | 1432.00 | 736.98 | 1259.90 | 1107.13 | 1223.83 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 1266.00 | 2447.95 | 1910.16 | 1947.05 | 1208.47 | |
Cash from Investing Activity Annual | -268.00 | -2706.75 | -2195.40 | 75.34 | -81.38 | |
Cash from Financing Annual Activity | -798.00 | -796.59 | -531.50 | -33.97 | -1091.25 | |
Net Cash Flow Annual | 200.00 | -1055.39 | -816.74 | 1988.42 | 35.84 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 508.83 | 478.64 | 440.44 | 349.28 | 275.63 | |
ROE Annual % | 11.68 | 14.23 | 25.21 | 21.08 | 18.76 | |
ROCE Annual % | 15.13 | 17.73 | 30.29 | 27.28 | 23.90 | |
Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EBDIT Annual Margin % | 32.75 | 35.36 | 44.90 | 42.40 | 37.76 |
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 2382.00 | 1950.00 | 1995.00 | 1859.00 | 2016.92 | 1821.93 | 1934.62 | 2342.91 | 2570.83 | 2509.86 | 2006.62 | 1996.61 | 1811.71 | |
Operating Expenses Qtr | 1572.00 | 1366.00 | 1430.00 | 1274.00 | 1463.18 | 1299.40 | 1233.50 | 1407.82 | 1414.01 | 1396.06 | 1169.44 | 1108.59 | 1071.93 | |
Operating Profit Qtr | 731.00 | 489.00 | 479.00 | 504.00 | 487.59 | 408.28 | 621.04 | 846.70 | 1104.43 | 1097.18 | 818.07 | 852.05 | 716.26 | |
EBIDT Qtr Cr | 810.00 | 584.00 | 565.00 | 585.00 | 553.74 | 522.53 | 701.12 | 935.09 | 1156.82 | 1113.80 | 837.18 | 888.02 | 739.78 | |
Depreciation Qtr | 95.00 | 95.00 | 95.00 | 93.00 | 87.02 | 86.77 | 85.73 | 83.66 | 80.99 | 79.91 | 77.35 | 73.26 | 70.08 | |
Net Profit Qtr | 538.00 | 358.00 | 348.00 | 356.00 | 320.97 | 306.80 | 493.60 | 702.01 | 894.64 | 902.24 | 606.46 | 557.11 | 502.02 | |
Basic EPS Qtr | 20.25 | 13.50 | 13.11 | 13.41 | 12.09 | 11.56 | 18.60 | 26.44 | 33.70 | 33.99 | 22.84 | 20.99 | 18.91 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 8184.00 | 8112.17 | 9073.70 | 7031.96 | 5584.05 | |
Operating Expenses Annual Cr | 5640.00 | 5399.69 | 5077.89 | 4109.46 | 3572.25 | |
Operating Profit Annual | 2205.00 | 2367.82 | 3881.94 | 2859.94 | 1822.17 | |
Operating Profit Margin Annual % | 26.94 | 29.19 | 42.78 | 40.67 | 32.63 | |
Total Expenses Annual Cr | 6021.00 | 5743.54 | 5390.20 | 4365.92 | 3764.59 | |
EBIDT Annual Cr | 2544.00 | 2712.48 | 3995.81 | 2922.50 | 2011.80 | |
EBIDT Annual margin % | 31.09 | 33.44 | 44.04 | 41.56 | 36.03 | |
Depreciation | 378.00 | 343.18 | 311.51 | 255.59 | 186.24 | |
PAT Before ExtraOrdinary Items Annual Cr | 1600.00 | 1823.38 | 2960.45 | 1984.29 | 1376.54 | |
Net Profit Annual | 1600.00 | 1823.38 | 2960.45 | 1984.29 | 1376.54 | |
Basic EPS Annual | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 13571.00 | 12767.09 | 11728.18 | 9294.61 | 7309.92 | |
Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non Current Liabilities Annual Cr | 621.00 | 570.60 | 450.98 | 367.00 | 298.95 | |
Total Current Liabilities Annual Cr | 1278.00 | 1101.08 | 1195.55 | 1112.46 | 926.83 | |
Total Capital Plus Liabilities Annual Cr | 15470.00 | 14438.77 | 13374.71 | 10774.07 | 8535.70 | |
Fixed Assets Annual | 5517.00 | 4934.48 | 4794.98 | 4414.49 | 3701.54 | |
Total Non Current Assets Annual | 5795.00 | 5127.03 | 5023.21 | 4599.36 | 3855.87 | |
Total Current Assets Annual | 9675.00 | 9311.74 | 8351.50 | 6174.71 | 4679.83 | |
Total Assets Annual | 15470.00 | 14438.77 | 13374.71 | 10774.07 | 8535.70 | |
Contingent Liabilities plus Commitments Annual Cr | 1432.00 | 736.98 | 1259.90 | 1107.13 | 1222.84 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 1261.00 | 2459.73 | 1911.80 | 1946.93 | 1215.94 | |
Cash from Investing Activity Annual | -269.00 | -2707.62 | -2194.92 | 75.13 | -83.47 | |
Cash from Financing Annual Activity | -799.00 | -797.17 | -532.44 | -34.89 | -1091.42 | |
Net Cash Flow Annual | 193.00 | -1045.06 | -815.56 | 1987.17 | 41.05 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 512.11 | 480.96 | 441.82 | 350.15 | 275.38 | |
ROE Annual % | 11.78 | 14.28 | 25.24 | 21.34 | 18.83 | |
ROCE Annual % | 15.26 | 17.76 | 30.25 | 27.60 | 23.99 | |
Total Debt to Total Equity Annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EBDIT Annual Margin % | 32.42 | 34.92 | 44.59 | 41.93 | 37.29 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
SBI MUTUAL FUND | 7.41 | 88991355 | - | - |
AXIS MUTUAL FUND TRUSTEE LIMITED | 1.6 | 88991356 | - | - |
GOVERNMENT PENSION FUND GLOBAL | 1.63 | 88991365 | - | - |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
NILIMA PRASAD DIVI | 20.34 | 88991345 | 0 | 0 |
SATCHANDRA KIRAN DIVI | 20.34 | 88991346 | 0 | 0 |
SWARNA LATHA DIVI | 5.27 | 88991347 | 0 | 0 |
MURALI KRISHNA PRASAD DIVI | 2.85 | 88991348 | 0 | 0 |
DIVI'S BIOTECH PRIVATE LIMITED | 3.01 | 88991352 | 0 | 0 |
Name | Holding Percent | Holding Id |
---|---|---|
SBI MUTUAL FUND | 7.41 | 88991355 |
AXIS MUTUAL FUND TRUSTEE LIMITED | 1.6 | 88991356 |
NIPPON LIFE INDIA TRUSTEE LTD | 1.07 | 88991357 |
GOVERNMENT PENSION FUND GLOBAL | 1.63 | 88991365 |
LIFE INSURANCE CORPORATION OF INDIA | 6.73 | 88991359 |
Name | Holding Percent | Holding Id |
---|
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Aug 02, 2024 | 30 | FINAL | Aug 02, 2024 | Equity Share |
Aug 11, 2023 | 30 | FINAL | Aug 11, 2023 | Equity Share |
Aug 11, 2022 | 30 | FINAL | Aug 12, 2022 | Equity Share |
Aug 17, 2021 | 20 | FINAL | - | Equity Share |
Feb 25, 2020 | 16 | INTERIM | Feb 26, 2020 | Equity Share |
Aug 14, 2019 | 16 | FINAL | - | Equity Share |
Aug 31, 2018 | 10 | FINAL | - | Equity Share |
Sep 15, 2017 | 10 | FINAL | - | Equity Share |
Mar 17, 2016 | 10 | INTERIM | Mar 18, 2016 | Equity Share |
Aug 06, 2015 | 20 | FINAL | - | Equity Share |
Jul 31, 2014 | 20 | FINAL | - | Equity Share |
Jul 25, 2013 | 15 | FINAL | - | Equity Share |
Jul 26, 2012 | 13 | FINAL | - | Equity Share |
Jun 16, 2011 | 10 | FINAL | - | Equity Share |
Jul 02, 2010 | 6 | FINAL | - | Equity Share |
Jun 15, 2009 | 6 | FINAL | - | Equity Share |
Jun 26, 2008 | 4 | FINAL | - | Equity Share |
Mar 23, 2007 | 10 | INTERIM | Mar 26, 2007 | Equity Share |
Aug 23, 2006 | 10 | FINAL | - | Equity Share |
Aug 11, 2005 | 8 | FINAL | - | Equity Share |
Jul 29, 2004 | 8 | FINAL | - | Equity Share |
Aug 11, 2003 | 6 | FINAL | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|---|---|
Aug 03, 2007 | 10:2 | - |
Ex-Date | Purpose | Notes |
---|---|---|
Aug 03, 2024 | Quarterly Results | - |
May 25, 2024 | Audited Results & Dividend | - |
Feb 10, 2024 | Quarterly Results | - |
Nov 06, 2023 | Quarterly Results | - |
Aug 14, 2023 | Quarterly Results | - |
May 20, 2023 | Audited Results & Final Dividend | - |
Feb 03, 2023 | Quarterly Results | - |
Nov 07, 2022 | Quarterly Results | - |
Aug 12, 2022 | Quarterly Results | - |
May 23, 2022 | Audited Results & Dividend | - |
Feb 11, 2022 | Quarterly Results | (Revised) |
Nov 06, 2021 | Quarterly Results | - |
Aug 07, 2021 | Quarterly Results | - |
May 29, 2021 | Audited Results & Final Dividend | - |
Feb 06, 2021 | Quarterly Results | - |
Nov 07, 2020 | Quarterly Results | - |
Aug 08, 2020 | Quarterly Results | - |
Jun 06, 2020 | Audited Results | - |
Feb 12, 2020 | Interim Dividend | - |
Feb 05, 2020 | Quarterly Results | - |
Nov 05, 2019 | Quarterly Results | - |
Aug 10, 2019 | Quarterly Results | - |
May 25, 2019 | Audited Results & Final Dividend | - |
Feb 02, 2019 | Quarterly Results | - |
Oct 27, 2018 | Quarterly Results | - |
Aug 04, 2018 | Quarterly Results | - |
May 26, 2018 | Audited Results & Dividend | - |
Jan 27, 2018 | Quarterly Results | - |
Oct 31, 2017 | Quarterly Results | - |
Jul 22, 2017 | Quarterly Results | - |
Jun 28, 2017 | Others | 1. Appointed Dr. Ramesh B. V. Nimmagadda as an Additional (Independent) Director w.e.f. 27th June, 2017. 2. Appointed Ms. Nilima Motaparti, as an Additional (Whole-time) Director w.e.f. 27th June,2017 |
May 26, 2017 | Audited Results & Dividend | - |
Feb 04, 2017 | Quarterly Results | - |
Nov 12, 2016 | Quarterly Results | - |
Aug 12, 2016 | Quarterly Results | - |
May 28, 2016 | Audited Results & Final Dividend | Interalia, has recommended the interim dividend declared as final dividend for the year ended March 31, 2016. |
Mar 10, 2016 | Interim Dividend | - |
Feb 05, 2016 | Quarterly Results | Approved to shift the Registered Office of the Company. |
Oct 31, 2015 | Quarterly Results | - |
Aug 08, 2015 | Quarterly Results | - |
May 23, 2015 | Audited Results & Dividend | - |
Jan 31, 2015 | Quarterly Results | - |
Nov 01, 2014 | Quarterly Results | - |
Aug 11, 2014 | Quarterly Results | - |
May 24, 2014 | Audited Results & Dividend | - |
Feb 03, 2014 | Quarterly Results | - |
Nov 08, 2013 | Quarterly Results | - |
Aug 03, 2013 | Quarterly Results | - |
May 20, 2013 | Audited Results & Dividend | - |
Feb 02, 2013 | Quarterly Results | - |
Nov 03, 2012 | Quarterly Results | - |
Aug 04, 2012 | Quarterly Results | - |
May 12, 2012 | Audited Results & Dividend | - |
Jan 28, 2012 | Quarterly Results | - |
Nov 01, 2011 | Quarterly Results | - |
Aug 06, 2011 | Quarterly Results | - |
May 20, 2011 | Audited Results & Dividend | - |
Feb 04, 2011 | Quarterly Results | - |
Nov 09, 2010 | Quarterly Results | - |
Aug 12, 2010 | Quarterly Results | - |
May 22, 2010 | Audited Results & Dividend | - |
Jan 29, 2010 | Quarterly Results | - |
Oct 30, 2009 | Quarterly Results | - |
Jul 31, 2009 | Quarterly Results | - |
Jun 06, 2009 | Audited Results, Dividend & Bonus | To recommend a issue of bonus shares in the ratio of one share for every share held, subject to approval of members. |
Apr 14, 2009 | Others | To seek shareholders approval by postal ballot for re-appointment of Mr. Madhusudana Rao Divi as Director (Projects) of the Co. & re-appointment of Mr. Kiran S Divi as Director of the Co. |
Jan 24, 2009 | Quarterly Results | - |
Oct 29, 2008 | Quarterly Results | - |
Jul 26, 2008 | Quarterly Results | - |
Jun 07, 2008 | Audited Results & Dividend | (Revised) |
Jan 28, 2008 | Quarterly Results | - |
Oct 27, 2007 | Quarterly Results | - |
Jul 30, 2007 | Quarterly Results | - |
May 23, 2007 | Audited Results & Stock Split | - |
Mar 17, 2007 | Interim Dividend | - |
Jan 27, 2007 | Quarterly Results | - |
Oct 28, 2006 | Quarterly Results | - |
Jul 31, 2006 | Quarterly Results | - |
Jun 17, 2006 | Accounts & Dividend | - |
Jan 30, 2006 | Quarterly Results & ESOP | - |
Oct 28, 2005 | Quarterly Results | - |
Jul 29, 2005 | Quarterly Results | - |
May 21, 2005 | Accounts & Dividend | - |
Jan 28, 2005 | Quarterly Results & Others | To consider the increasing of the limits of shareholding of Foreign Institutional Investors in the company. |
Oct 21, 2004 | Quarterly Results | (Revised) |
Jul 28, 2004 | Quarterly Results | - |
May 17, 2004 | Dividend & Accounts | - |
Jan 27, 2004 | Quarterly Results | - |
Oct 24, 2003 | Quarterly Results | - |
Jul 30, 2003 | Quarterly Results | - |
May 22, 2003 | Dividend & Accounts | - |
Ex-Date | Bonus Ratio | Record Date |
---|---|---|
Sep 23, 2015 | 1:1 | 2015-09-26 |
Jul 30, 2009 | 1:1 | 2009-08-01 |
DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2024.
DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2024 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2024.Divis Labs: What should investors do?
The stock trades above its premium valuation anticipating strong growthDIVI'S LABORATORIES LTD. - 532488 - US-FDA Inspection Of Company'S Unit-II Manufacturing Facility At Visakhapatnam, Andhra Pradesh
As per enclosed letter.DIVI'S LABORATORIES LTD. - 532488 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
As per enclosed letter.DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication regarding 34th AGM, E-voting and other information.DIVI'S LABORATORIES LTD. - 532488 - Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the financial year ended March 31, 2024.DIVI'S LABORATORIES LTD. - 532488 - Notice Of 34Th Annual General Meeting To Be Held On Monday, August 12, 2024 At 10.00 A.M. IST Through Video Conferencing (VC) / Other Audio-Visual Means (OAVM)
Please find the enclosed Notice of 34th Annual General Meeting of the Company.DIVI'S LABORATORIES LTD. - 532488 - Reg. 34 (1) Annual Report.
The 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Monday, August 12, 2024 at 10.00 a.m. IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Notice convening the 34th AGM of the Company and Annual Report for the financial year 2023-24, being sent to the members through electronic mode. The Annual Report 2023-24 containing the Notice of the 34th AGM is also uploaded on the Company's website at https://www.divislabs.com/investor-relations/reports-and-filings/annual-reporting/.DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Clippings related to notice to shareholders regarding 34th Annual General Meeting, Record date for dividend and other informationDIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window
Intimation of Trading Window closure from July 01, 2024 till 48 hours after the declaration of unaudited financial results of the Company for the quarter ending June 30, 2024.The latest market price of Divi's Laboratories Ltd. on NSE was Rs. 4790.60 as of today.
The opening share price of Divi's Laboratories Ltd. was Rs. 4571.00 as of today.
The 52-week high share price of Divi's Laboratories Ltd. was Rs. 4810.00.
The 52 week low share price of Divi's Laboratories Ltd. was Rs. 3295.30.
The PE ratio of Divi's Laboratories Ltd. is -6.50. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
The latest dividend declared by Divi's Laboratories Ltd. was on 2024-08-02 for Rs. 30 per share. According to today’s share price, the dividend yield of Divi's Laboratories Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.
The latest bonus issue declared by Divi's Laboratories Ltd. was as of 2015-09-23. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.
The latest split issue declared by Divi's Laboratories Ltd. was as of 2007-08-03. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Divi's Laboratories Ltd..